Skincare Manufacturer UK or US: Which Rules Follow Your Brand
If you are searching for a skincare manufacturer UK side by side with a US facility, you are not comparing two price lists. You are comparing two legal regimes. In Great Britain the duty attaches to a UK-established Responsible Person, who must notify every product to the Office for Product Safety and Standards before it reaches a consumer. In the United States the factory registers with the FDA, while the brand named on the label carries product listing, safety records and adverse event reporting. Neither system lets a manufacturer absorb your obligations, which is why the location question matters less than most founders expect.
What the GB regime actually asks for
Great Britain does not run a factory register. It runs a product register. Every cosmetic product available to consumers in GB must have a Responsible Person, and that Responsible Person must have a UK established address — OPSS guidance states explicitly that this “does not include mail forwarding or PO box addresses”. The Responsible Person can be the manufacturer, the importer, the distributor if it labels the product under its own brand, or an appointed company.
That person, not the factory, is the one who has to keep a Product Information File for ten years after the last batch was made available, have the formula assessed by a qualified safety assessor before sale, notify the product through the Submit cosmetic product notifications service, report serious undesirable effects, and be able to prove any marketing claim. The notification service warns that skipping it carries a fine and a prison term of up to three months. Northern Ireland is a separate case: the Responsible Person there must be established in NI or the EU and notify the EU portal instead.
OPSS published figures in July 2026 showing 861,686 notifications since the service launched, from 24,112 registered Responsible Persons.
What a US facility registration is, and is not
The United States works the other way round. Under the Modernization of Cosmetics Regulation Act of 2022, any establishment that manufactures or processes cosmetic products distributed in the US must register that facility with the FDA and renew the registration every two years from the date of initial registration. The FDA can suspend a registration, and distributing product from a suspended facility is a prohibited act.
Separately, the “responsible person” — the manufacturer, packer or distributor whose name appears on the label — must list each marketed product with the FDA including its ingredients, update that listing annually, maintain records substantiating the product’s safety, and report serious adverse events within 15 business days.
Two details catch founders out. First, the FDA does not issue certificates confirming that a facility is registered, and states that a registration number “does not indicate FDA approval of the facility or its cosmetic products”. Cosmetics and their ingredients, color additives aside, do not require FDA premarket approval at all. Second, a registered facility is not a compliance shortcut for your label: structure or function claims can move a cosmetic into drug territory regardless of who made it.
Where the two systems get confused
The common error is assuming the market you sell into decides where you must manufacture. It does not. FDA guidance is direct on this: a contract manufacturer making products distributed in the US must be registered with the FDA even if it sits outside the United States, and following ISO 22716 is not an exemption from registration. A foreign facility also needs a US agent for registration purposes.
Running it the other way, a US-made product sold in Great Britain still needs a UK-established Responsible Person, a safety assessment and an OPSS notification. The factory’s own registrations do nothing for that. And imported cosmetics entering the US must meet the same rules as domestic ones, with labeling in English and color additive identification numbers verified at the border.
Practical takeaways
- Ask a prospective manufacturer which regimes its facility is registered under, and for the renewal date rather than a certificate — for US registration, no certificate exists.
- Budget for a Responsible Person in every market you sell in. In GB that address has to be a real UK establishment.
- Decide early who holds the safety documentation. A US responsible person keeps safety substantiation records; a GB Responsible Person keeps a Product Information File for ten years.
- Have your claims reviewed before the formula is locked, not after. Intended use is set by your marketing, not by the factory.
- Keep the two timetables apart: US facility registration renews every two years, US product listings update annually, and GB notifications are per product before launch.
So does the manufacturer’s country matter?
It matters for logistics, import handling and which agent you need, not for whether the duty transfers. The practical question is whether a manufacturer can tell you precisely what it holds and what you hold. Moe’s Group is an FDA registered contract manufacturer in Chatsworth, California, formulating, filling and labeling skincare, hair care and body care in the same facility, with a 200-unit minimum on ready-to-go white label formulas and a 1,000-unit minimum on custom formulation, and capacity of up to 1,000,000 units a month. What it cannot do — what no factory can — is become the Responsible Person named on your label.
If you are weighing where to have your line made and want the regulatory split set out against your actual markets, send us the brief.
Moe’s Group Newsroom
